Apr. 14 at 10:33 PM
$CPB Buy Zone and Contrarian Entry: Betting Against Peak Hate in Consumer Defensive Packaged Foods
Initiated a long CPB position today via short puts (second trade this year). Sold the Jun
$19 s. Breakeven
$18.17, which puts me right in the middle of the shelf I've marked on the monthly chart and... stop and think about this for a second... back at price levels this stock traded at in the 1990s. Three decades of nominal appreciation erased. The pendulum always swings too far in both directions, and I think it's swinging too far right now. Worth noting: I'm selling closer to the money than I normally do. My usual premium-selling playbook stays under a 0.20 delta, typically in the .14–.18 range. Not here. This one I actually want to own, so I'm willing to accept higher assignment probability in exchange for a cost basis that lines up with the level the chart tells me matters.
The setup:
– Monthly RSI at 19. Not weekly. Monthly. I can't remember the last time I saw a name in the S&P print a monthly RSI that low outside of a genuine crisis
– Weekly stochastics under 7, daily stochastics under 10... washed on every timeframe
– Down ~49% from the 52-week high, sitting roughly 31% below the 200-day SMA... the degree of detachment from the long-term trend is historically rare for a defensive packaged-foods name
– The monthly volume bar printed into this low is the largest in the chart's recorded history. That is not distribution. That is capitulation... forced selling, index rebalancing, tax-loss harvesting, and the last of the long-term holders throwing in the towel
– Short float 18.76%. When nearly one out of every five shares is short a consumer staple with a 7.8% dividend yield, you are looking at peak hate
The thesis:
I traded this name earlier in the year via LEAPS and cash-secured puts and was fortunate to close both into the run to ~
$29. TBH... I did not think it would come back and take out those lows, but here we are, and the setup is arguably much better now than it was then. These businesses will adapt. They always have. The GLP-1 narrative, the private label pressure, the margin compression from commodity costs... all real, all already in the tape at 8.96x forward earnings and 0.59x sales.
I also think there's a very real probability of M&A in this space over the next 12–24 months. Packaged foods at these valuations with cash flow profiles this stable don't stay independent forever. Whether it's a strategic buyer, a PE take-private, or a cross-border merger, the risk from here skews up, not down. The people shorting these names with impunity right now are making the same bet the bears made on retail in 2001 -- that the category itself is finished. It isn't. It's just unloved.
Bear case I'm respecting:
The real risks here are the debt load (Debt/Eq 1.85), ongoing margin pressure from commodity costs and private label competition, and Sovos integration execution. If comps roll further and management is forced to guide down again, my
$19 strike gets tested and assignment is on the table. Which is what I want.
On the dividend:
Yes, the 7.82% yield looks fragile and a cut is very much on the table, but I'd argue that outcome is already in the tape. This is what a market pricing in a dividend reduction looks like. If management actually rebases it to redirect cash toward debt paydown and integration, I think the stock rallies on the news... the overhang clears, the shorts lose their primary thesis, and what's left are holders who want the business, not the accidental high-yield coupon. Classic sell-the-rumor, buy-the-news setup near a capitulation low.
Plan:
I'll let these puts ride. If the tape takes this deep into the buy zone on my monthly chart -- that
$18.84 midline or lower -- I accelerate in three ways: buy the common outright, sell additional puts at lower strikes, and start layering in call LEAPS for the longer-dated asymmetric upside. I'm not trying to be cute with entry here. I'm trying to accumulate a name that I think is printing a generational valuation at a moment of peak narrative disgust.
Mean reversion is a patient game, y'all, but when it shows up in a name this detached from its long-term trend, the move is usually every bit as remarkable as the decline that preceded it. Stay tuned!
Just my read. NFA. Please do your own homework/DD.
$GIS $SJM $KHC
